Drug that can keep breast cancer at bay for longer

Breakthrough drug that can keep breast cancer at bay for longer Breakthrough: Women on pertuzumab alongside “wonder” drug Herceptin lived for 18 months without symptoms worsening A breakthrough drug gives women suffering an aggressive form of breast cancer an extra six months before the disease advances. Women on a combination treatment of pertuzumab alongside the ‘wonder’ drug Herceptin lived on average for 18 months without their disease worsening, compared with 12 months for those not taking it